These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 35114211)

  • 21. Affordable inactivated poliovirus vaccine: strategies and progress.
    Okayasu H; Sutter RW; Jafari HS; Takane M; Aylward RB
    J Infect Dis; 2014 Nov; 210 Suppl 1():S459-64. PubMed ID: 25316868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives for the creation of a new type of vaccine preparations based on pseudovirus particles using polio vaccine as an example.
    Zhdanov DD; Ivin YY; Shishparenok AN; Kraevskiy SV; Kanashenko SL; Agafonova LE; Shumyantseva VV; Gnedenko OV; Pinyaeva AN; Kovpak AA; Ishmukhametov AA; Archakov AI
    Biomed Khim; 2023 Nov; 69(5):253-280. PubMed ID: 37937429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemical and biophysical characterization of inactivated Sabin poliovirus products: Insights into rapid quality assessment tools.
    Westdijk J; Kogelman A; van der Put R; Eksteen Z; Suarez D; Kersten GFA; Metz B; Danial M
    J Pharm Sci; 2022 Apr; 111(4):1058-1069. PubMed ID: 35114211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains.
    Verdijk P; Rots NY; Bakker WA
    Expert Rev Vaccines; 2011 May; 10(5):635-44. PubMed ID: 21604984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Universal use of inactivated poliovirus vaccine--the needs and challenges].
    Shimizu H; Takeda N
    Nihon Rinsho; 2008 Oct; 66(10):1950-5. PubMed ID: 18939495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of inactivated poliovirus vaccine from Sabin strains: A progress report.
    Okayasu H; Sein C; Hamidi A; Bakker WA; Sutter RW
    Biologicals; 2016 Nov; 44(6):581-587. PubMed ID: 27720268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.